StockData
CASI Pharmaceuticals, Inc. logo

CASI Pharmaceuticals, Inc. (CASIF) stock

CASIFOTCPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 20-F on May 15, 2026Score 1/30
$0.10+0.00 (0.00%)

Close on Oct 19, 2026Market cap –P/E –Yield –

CASI Pharmaceuticals price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

CASI Pharmaceuticals's price to sales ratio was 0.1× on Oct 19, 2026, against 0.8× a year earlier. Over the last 5 years it ranged from 0.1× to 7.8×, with a median of 1.0×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Oct 19, 20260.1×−0.4
2025Dec 31, 20250.5×−0.7
2024Dec 31, 20241.1×−1.1
2023Dec 29, 20232.2×+1.4
2022Dec 30, 20220.8×−5.0
2021Dec 31, 20215.8×–

More CASI Pharmaceuticals figures

See a number that looks wrong?